IPI and Pfizer Launch Multiparticulate Device Challenge

Program Seeks Innovative Proposals for Dispensing Pediatric Drug Formulations

IPI is thrilled to announce the launch of the Pediatric Device Challenge, run through a partnership with Pfizer. We seek individuals and groups with innovative ideas for the design of a device that can measure and administer medication to pediatric patients.  We’re looking for device design proposals that will be appropriate for use in low resource settings, where pediatric drug availability and access are especially important problems to address.

We believe that “less is more” and seek to minimize device complexity while maximizing device utility. Designs need to be child-friendly, child-misuse resistant, and capable of delivering doses relevant for therapy in low-resource settings.

Any winning applicant will be eligible for up to $50,000 of grant funding provided by Pfizer. For those seeking more information, there will be a Q&A session held via conference call on April 12, 2016 at 11:00am-noon EDT. The deadline for letters of intent is May 16, 2016. Instructions for applications and registration for the informational conference call can be found at: http://www.pfizer.com/responsibility/grants_contributions/device_challenge

The XStraw® – the new oral drug delivery device for pellets thanks to innovative technology
The XStraw® provides a new and convenient alternative to drug intake. Especially for children and the elderly, intake method in addition to taste, play an important role. At the same time, safe intake and perfect dosage are often the decisive factor.

More Information

You might also like